Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Clin Geriatr Med. 2016 Feb;32(1):155–173. doi: 10.1016/j.cger.2015.08.010

TABLE 1.

Overall survival and risk of AML evolution by revised IPSS score

Risk Group IPSS-R score Median overall Survival (years) Median time to 25 percent AML evolution (years)
Very low <1.5 8.8 >14.5
Low <1.5 to 3.0 5.3 10.8
Intermediate >3 to 4.5 3.0 3.2
High >4.5 to 6 1.6 1.4
Very high >6 0.8 0.7

Data from Greenberg PL, Tuechler H, Schanz J, et al. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood. 2012 Sep 20;120(12):2454-65.